TMED6 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the TMED6 protein, a member of the p24 family involved in intracellular transport and vesicle trafficking. These inhibitors function by binding to key regions of the TMED6 protein, such as the active site or other important functional domains, blocking its role in mediating protein transport between cellular compartments. TMED6 inhibitors may also bind to allosteric sites, which are regions of the protein removed from the active site but capable of inducing conformational changes that impair the protein's function. By occupying these critical regions, TMED6 inhibitors prevent the protein from interacting with its natural partners or substrates, effectively disrupting its role in the vesicular trafficking processes. The binding between TMED6 inhibitors and the protein is maintained by a range of non-covalent interactions, including hydrogen bonds, hydrophobic contacts, van der Waals forces, and ionic interactions, ensuring that the inhibitors remain stably associated with the protein.
Structurally, TMED6 inhibitors exhibit a wide range of chemical diversity, allowing for precise interactions with the TMED6 protein's binding pockets. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate hydrogen bonding and ionic interactions with amino acid residues in the TMED6 protein. Many TMED6 inhibitors also feature aromatic rings and heterocyclic structures, which enhance hydrophobic interactions with non-polar regions of the protein, stabilizing the inhibitor-protein complex. The physicochemical properties of TMED6 inhibitors, including molecular weight, solubility, polarity, and lipophilicity, are carefully optimized to ensure that the inhibitors bind effectively and remain stable across various biological environments. The balance between hydrophilic and hydrophobic regions within the inhibitors allows them to interact with both polar and non-polar areas of the protein, ensuring that they achieve strong, selective binding and robust inhibition of the TMED6 protein under different cellular conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of GDP to GTP on ARF proteins, which could affect TMED6-mediated transport. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A polyether antibiotic that disrupts Golgi function, which can interfere with TMED6's role in protein trafficking. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, which can affect the folding and transport of glycoproteins involving TMED6. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, which can reduce the overall levels of TMED6 by preventing its translation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor that causes ER stress, possibly disrupting TMED6 function in protein trafficking. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
Induces intracellular cholesterol accumulation, which can alter membrane trafficking pathways including those associated with TMED6. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Alters endosomal and lysosomal pH, which can affect the endosomal sorting pathways that involve TMED6. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
A GTPase inhibitor that blocks dynamin-dependent endocytosis, potentially affecting TMED6's role in vesicular transport. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disrupts microtubule polymerization, potentially interfering with vesicular transport processes where TMED6 is involved. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that can alter vesicular trafficking, potentially affecting the functions of TMED6. | ||||||